Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Agammaglobulinemia | 11 | 2024 | 174 | 5.150 |
Why?
|
Common Variable Immunodeficiency | 6 | 2024 | 100 | 2.770 |
Why?
|
Immunologic Deficiency Syndromes | 7 | 2024 | 549 | 1.890 |
Why?
|
Severe Combined Immunodeficiency | 3 | 2024 | 235 | 0.930 |
Why?
|
Hashimoto Disease | 1 | 2024 | 108 | 0.850 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2022 | 56 | 0.790 |
Why?
|
Neutropenia | 2 | 2023 | 892 | 0.710 |
Why?
|
Encephalitis | 1 | 2024 | 441 | 0.710 |
Why?
|
Ataxia Telangiectasia | 1 | 2020 | 107 | 0.660 |
Why?
|
Immunologic Tests | 1 | 2019 | 104 | 0.630 |
Why?
|
Allergy and Immunology | 1 | 2020 | 175 | 0.620 |
Why?
|
Angioedemas, Hereditary | 1 | 2019 | 91 | 0.580 |
Why?
|
Cytological Techniques | 1 | 2019 | 217 | 0.580 |
Why?
|
Viral Vaccines | 1 | 2022 | 596 | 0.540 |
Why?
|
Perforin | 1 | 2016 | 167 | 0.510 |
Why?
|
Diarrhea | 1 | 2022 | 1320 | 0.500 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.500 |
Why?
|
Desensitization, Immunologic | 2 | 2020 | 558 | 0.480 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 306 | 0.470 |
Why?
|
Gastrointestinal Tract | 2 | 2019 | 840 | 0.470 |
Why?
|
Drug Hypersensitivity | 2 | 2020 | 923 | 0.450 |
Why?
|
B-Lymphocytes | 4 | 2025 | 4793 | 0.420 |
Why?
|
Anaphylaxis | 1 | 2020 | 758 | 0.420 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2017 | 386 | 0.420 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2016 | 271 | 0.390 |
Why?
|
Pruritus Ani | 1 | 2011 | 1 | 0.370 |
Why?
|
Leukocytes | 1 | 2019 | 2035 | 0.370 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2015 | 667 | 0.360 |
Why?
|
Dermatitis, Contact | 1 | 2011 | 134 | 0.350 |
Why?
|
Nickel | 1 | 2011 | 126 | 0.350 |
Why?
|
X Chromosome Inactivation | 2 | 2024 | 229 | 0.340 |
Why?
|
Genetic Testing | 2 | 2020 | 3591 | 0.330 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13676 | 0.300 |
Why?
|
Cause of Death | 1 | 2018 | 3721 | 0.290 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4568 | 0.290 |
Why?
|
Immunophenotyping | 4 | 2024 | 1864 | 0.290 |
Why?
|
Lymphocyte Activation | 3 | 2025 | 5505 | 0.240 |
Why?
|
Quality of Life | 2 | 2024 | 13490 | 0.240 |
Why?
|
Leukocyte-Adhesion Deficiency Syndrome | 1 | 2024 | 22 | 0.230 |
Why?
|
Receptors, Antigen, T-Cell | 4 | 2023 | 2568 | 0.230 |
Why?
|
Splenomegaly | 1 | 2024 | 192 | 0.220 |
Why?
|
Mass Screening | 1 | 2018 | 5458 | 0.200 |
Why?
|
Humans | 39 | 2025 | 768166 | 0.200 |
Why?
|
Warts | 1 | 2022 | 66 | 0.200 |
Why?
|
Nephritis, Interstitial | 1 | 2023 | 158 | 0.190 |
Why?
|
Immunologic Memory | 2 | 2019 | 1377 | 0.180 |
Why?
|
T-Lymphocytes | 4 | 2025 | 10266 | 0.180 |
Why?
|
Lymphopenia | 1 | 2022 | 300 | 0.170 |
Why?
|
Hypertension, Portal | 1 | 2022 | 230 | 0.170 |
Why?
|
Immunotherapy | 1 | 2015 | 4755 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.160 |
Why?
|
Neonatal Screening | 2 | 2021 | 620 | 0.160 |
Why?
|
Immunoglobulins | 1 | 2022 | 855 | 0.150 |
Why?
|
Iatrogenic Disease | 1 | 2022 | 552 | 0.150 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2017 | 36 | 0.140 |
Why?
|
Chromosomes, Human, X | 1 | 2019 | 320 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 398 | 0.140 |
Why?
|
Immunoglobulin Isotypes | 1 | 2017 | 158 | 0.140 |
Why?
|
Fever | 1 | 2024 | 1614 | 0.130 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1082 | 0.130 |
Why?
|
NF-kappa B | 1 | 2024 | 2493 | 0.130 |
Why?
|
Immunity | 1 | 2022 | 1003 | 0.130 |
Why?
|
Lymphocyte Subsets | 1 | 2017 | 313 | 0.130 |
Why?
|
Liver Diseases | 1 | 2024 | 1305 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2023 | 1014 | 0.130 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1512 | 0.120 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 659 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 842 | 0.120 |
Why?
|
Preventive Health Services | 1 | 2019 | 570 | 0.110 |
Why?
|
Immunoglobulin Class Switching | 1 | 2015 | 289 | 0.110 |
Why?
|
Pruritus | 1 | 2017 | 379 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 22371 | 0.100 |
Why?
|
Adult | 10 | 2024 | 223646 | 0.100 |
Why?
|
Drug Monitoring | 1 | 2018 | 964 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.100 |
Why?
|
Young Adult | 6 | 2024 | 60066 | 0.100 |
Why?
|
Interleukins | 1 | 2017 | 796 | 0.100 |
Why?
|
Male | 12 | 2025 | 364719 | 0.100 |
Why?
|
Outpatients | 1 | 2019 | 1600 | 0.090 |
Why?
|
Health Status | 1 | 2024 | 4091 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2016 | 1836 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2050 | 0.090 |
Why?
|
Homozygote | 1 | 2016 | 1779 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1406 | 0.090 |
Why?
|
Patch Tests | 1 | 2011 | 57 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1942 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2019 | 2059 | 0.080 |
Why?
|
Aged | 7 | 2024 | 171504 | 0.080 |
Why?
|
Dermatitis, Atopic | 1 | 2017 | 737 | 0.080 |
Why?
|
Pedigree | 1 | 2017 | 4539 | 0.080 |
Why?
|
Brain | 1 | 2016 | 27360 | 0.080 |
Why?
|
Middle Aged | 7 | 2024 | 223492 | 0.080 |
Why?
|
Child | 6 | 2024 | 80917 | 0.080 |
Why?
|
Prevalence | 3 | 2024 | 15869 | 0.080 |
Why?
|
Infant | 3 | 2021 | 36535 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7577 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1206 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2536 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2744 | 0.070 |
Why?
|
Chronic Disease | 1 | 2022 | 9384 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.070 |
Why?
|
Female | 10 | 2025 | 397192 | 0.070 |
Why?
|
Adolescent | 5 | 2024 | 89169 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8542 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3782 | 0.070 |
Why?
|
Computer Simulation | 1 | 2020 | 6283 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2024 | 26422 | 0.070 |
Why?
|
Risk Factors | 3 | 2024 | 74944 | 0.070 |
Why?
|
Signal Transduction | 3 | 2025 | 23645 | 0.070 |
Why?
|
Melanoma | 1 | 2024 | 5706 | 0.060 |
Why?
|
Genomics | 1 | 2022 | 5926 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26379 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9263 | 0.060 |
Why?
|
Relapsing Fever | 1 | 2024 | 25 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12543 | 0.060 |
Why?
|
rac GTP-Binding Proteins | 1 | 2024 | 163 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9419 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2025 | 528 | 0.050 |
Why?
|
Superoxides | 1 | 2024 | 389 | 0.050 |
Why?
|
Seizures | 1 | 2016 | 2998 | 0.050 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2024 | 246 | 0.050 |
Why?
|
Digestive System Diseases | 1 | 2024 | 152 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5717 | 0.050 |
Why?
|
B-Cell Maturation Antigen | 1 | 2023 | 149 | 0.050 |
Why?
|
Granuloma | 1 | 2024 | 329 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18412 | 0.050 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2024 | 175 | 0.050 |
Why?
|
Mutation | 2 | 2017 | 30238 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15948 | 0.040 |
Why?
|
Mice | 4 | 2024 | 82029 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2024 | 879 | 0.040 |
Why?
|
Cohort Studies | 2 | 2024 | 41754 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 18065 | 0.040 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2019 | 85 | 0.040 |
Why?
|
Ribonucleotides | 1 | 2019 | 114 | 0.040 |
Why?
|
United States | 2 | 2024 | 73039 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1151 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16726 | 0.040 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 599 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2019 | 65371 | 0.040 |
Why?
|
5'-Nucleotidase | 1 | 2019 | 164 | 0.040 |
Why?
|
B-Lymphocyte Subsets | 1 | 2019 | 241 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 472 | 0.040 |
Why?
|
Receptors, CXCR4 | 1 | 2022 | 729 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.040 |
Why?
|
Epitope Mapping | 1 | 2017 | 301 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13671 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2019 | 596 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2024 | 1397 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2023 | 1895 | 0.030 |
Why?
|
Animals | 4 | 2024 | 169246 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 905 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2019 | 610 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2025 | 11669 | 0.030 |
Why?
|
Bone Marrow | 1 | 2024 | 2935 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36743 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1670 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2024 | 2100 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2019 | 1089 | 0.030 |
Why?
|
Autoantigens | 1 | 2017 | 890 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22379 | 0.030 |
Why?
|
Child, Preschool | 1 | 2015 | 42669 | 0.030 |
Why?
|
Keratinocytes | 1 | 2017 | 876 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3216 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8509 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59629 | 0.020 |
Why?
|
Neutrophils | 1 | 2024 | 3786 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2025 | 3114 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2124 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3437 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9669 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5027 | 0.020 |
Why?
|
Autoimmunity | 1 | 2017 | 1361 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 13014 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 81762 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4362 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10399 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3348 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7477 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2540 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4428 | 0.020 |
Why?
|
Computational Biology | 1 | 2017 | 3568 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3671 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9561 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 19015 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9538 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11095 | 0.010 |
Why?
|
Skin | 1 | 2017 | 4503 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22291 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20760 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39348 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18349 | 0.010 |
Why?
|
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(73)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_